首页> 外文期刊>Diabetes >Mechanisms Underlying the Onset of Oral Lipid-Induced Skeletal Muscle Insulin Resistance in Humans
【24h】

Mechanisms Underlying the Onset of Oral Lipid-Induced Skeletal Muscle Insulin Resistance in Humans

机译:人体口服脂质诱导骨骼肌胰岛素抵抗发作的潜在机制

获取原文
获取原文并翻译 | 示例
       

摘要

Several mechanisms, such as innate immune responses via Toll-like receptor-4, accumulation of diacylglycerols (DAG)/ ceramides, and activation of protein kinase C (PKC), are considered to underlie skeletal muscle insulin resistance. In this study, we examined initial events occurring during the onset of insulin resistance upon oral high-fat loading compared with lipid and low-dose endotoxin infusion. Sixteen lean insulin-sensitive volunteers received intravenous fat (iv fat), oral fat (po fat), intravenous endotoxin (lipopolysaccharide [LPS]), and intravenous glycerol as control. After 6 h, whole-body insulin sensitivity was reduced by iv fat, po fat, and LPS to 60, 67, and 48%, respectively (all P < 0.01), which was due to decreased nonoxidative glucose utilization, while hepatic insulin sensitivity was unaffected. Muscle PKCθ activation increased by 50% after iv and po fat, membrane Di-C18:2 DAG species doubled after iv fat and correlated with PKCθ activation after po fat, whereas ceramides were unchanged. Only after LPS, circulating inflammatory markers (tumor necrosis factor-α, interleukin-6, and interleukin-1 receptor antagonist), their mRNA expression in subcutaneous adipose tissue, and circulating cortisol were elevated. Po fat ingestion rapidly induces insulin resistance by reducing nonoxidative glucose disposal, which associates with PKCθ activation and a rise in distinct myocellular membrane DAG, while endotoxin-induced insulin resistance is exclusively associated with stimulation of inflammatory pathways.
机译:几种机制被认为是骨骼肌胰岛素抵抗的基础,例如通过Toll样受体4产生的先天免疫应答,二酰基甘油(DAG)/神经酰胺的积累以及蛋白激酶C(PKC)的激活。在这项研究中,我们检查了与高脂和低剂量内毒素输注相比,口服高脂负荷胰岛素抵抗发作期间发生的初始事件。 16名对胰岛素敏感的瘦身志愿者接受了静脉内脂肪(iv脂肪),口服脂肪(po脂肪),静脉内毒素(脂多糖[LPS])和静脉内甘油作为对照。 6小时后,由于非氧化葡萄糖利用率降低,而静脉内脂肪,po脂肪和LPS使全身胰岛素敏感性分别降低至60%,67%和48%(所有P <0.01),而肝脏胰岛素敏感性降低不受影响。静脉和口服脂肪后肌肉PKCθ激活增加了50%,在静脉注射脂肪后膜Di-C18:2 DAG种类增加了一倍,并与口服脂肪后PKCθ激活相关,而神经酰胺未改变。仅在LPS后,循环炎症标志物(肿瘤坏死因子-α,白介素6和白介素1受体拮抗剂),其在皮下脂肪组织中的mRNA表达和循环皮质醇升高。 Po脂肪的摄入通过减少非氧化性葡萄糖处置而迅速诱导胰岛素抵抗,这与PKCθ活化和独特的肌细胞膜DAG升高有关,而内毒素诱导的胰岛素抵抗仅与刺激炎症途径有关。

著录项

  • 来源
    《Diabetes》 |2013年第7期|2240-2248|共9页
  • 作者单位

    Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany,University Clinics for Endocrinology and Diabetology, Heinrich Heine University, Dusseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany;

    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut;

    Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany,University Clinics for Endocrinology and Diabetology, Heinrich Heine University, Dusseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany;

    Institute for Biochemistry and Pathobiochemistry, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Dusseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany,University Clinics for Endocrinology and Diabetology, Heinrich Heine University, Dusseldorf, Germany;

    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut,Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut,Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut.;

    Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Duesseldorf, Germany,University Clinics for Endocrinology and Diabetology, Heinrich Heine University, Dusseldorf, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:26

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号